Assessment of Helicobacter pylori eradication in patients on NSAID treatment

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  Vonkeman, Harald E ^a   deLeest, H T J I ^b   van deLaar, M A F J ^a   vanBaarlen, J ^c   Steen, K S S ^b   Lems, W F ^b   Bijlsma, J W J ^d   Kuipers, E J ^e   Houben, H H M L ^f   Janssen, M ^g   Dijkmans, B A C ^b  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Laboratorium Pathologie Oost Nederland   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f Zuyderland Medical Centre   (Netherlands)

^g RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BACTERIUM ANTIBODY; CLARITHROMYCIN; DICLOFENAC; EOSIN; HEMATOXYLIN; IBUPROFEN; IMMUNOGLOBULIN G ANTIBODY; METRONIDAZOLE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PLACEBO;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG RESPONSE; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; ERADICATION THERAPY; FEMALE; GOLD STANDARD; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; POST HOC ANALYSIS; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STAINING; STOMACH BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, BACTERIAL; DOUBLE-BLIND METHOD; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; ROC CURVE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84866499834     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-133     Document Type: Article

References (40)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984, 1:1311-1315.
2. Rauws EA, Tytgat GN. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990, 335:1233-1235. 10.1016/0140-6736(90)91301-P, 1971318.
3. Montalban C, Manzanal A, Boixeda D, Redondo C, Bellas C. Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication. Lancet 1995, 345:798-799. 10.1016/S0140-6736(95)90679-7, 7891510.
4. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991, 325:1127-1131. 10.1056/NEJM199110173251603, 1891020.
5. Kullavanijaya P, Thong-Ngam D, Hanvivatvong O, Nunthapisud P, Tangkijvanich P, Suwanagool P. Analysis of eight different methods for the detection of Helicobacter pylori infection in patients with dyspepsia. J Gastroenterol Hepatol 2004, 19:1392-1396. 10.1111/j.1440-1746.2004.03506.x, 15610313.
6. Talley NJ, Newell DG, Ormand JE, Carpenter HA, Wilson WR, Zinsmeister AR, Perez-Perez GI, Blaser MJ. Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays. J Clin Microbiol 1991, 29:1635-1639. 270176, 1761685.
7. Oksanen A, Veijola L, Sipponen P, Schauman KO, Rautelin H. Evaluation of Pyloriset Screen, a rapid whole-blood diagnostic test for Helicobacter pylori infection. J Clin Microbiol 1998, 36:955-957. 104667, 9542915.
8. Perez-Perez GI, Dworkin BM, Chodos JE, Blaser MJ. Campylobacter pylori antibodies in humans. Ann Intern Med 1988, 109:11-17.
9. Lahner E, Bordi C, Di GE, Caruana P, D'Ambra G, Milione M, Grossi C, Delle FG, Annibale B. Role of Helicobacter pylori serology in atrophic body gastritis after eradication treatment. Aliment Pharmacol Ther 2002, 16:507-514. 10.1046/j.1365-2036.2002.01213.x, 11876704.
10. Bergey B, Marchildon P, Peacock J, Megraud F. What is the role of serology in assessing Helicobacter pylori eradication?. Aliment Pharmacol Ther 2003, 18:635-639. 10.1046/j.1365-2036.2003.01716.x, 12969090.
11. Lerang F, Moum B, Mowinckel P, Haug JB, Ragnhildstveit E, Berge T, Bjorneklett A. Accuracy of seven different tests for the diagnosis of Helicobacter pylori infection and the impact of H2-receptor antagonists on test results. Scand J Gastroenterol 1998, 33:364-369. 10.1080/00365529850170982, 9605257.
12. Bermejo F, Boixeda D, Gisbert JP, Sanz JM, Canton R, Defarges V, Martin-de-Argila C. Concordance between noninvasive tests in detecting Helicobacter pylori and potential use of serology for monitoring eradication in gastric ulcer. J Clin Gastroenterol 2000, 31:137-141. 10.1097/00004836-200009000-00009, 10993429.
13. Kawai T, Kawakami K, Kudo T, Ogiahara S, Handa Y, Moriyasu F. A new serum antibody test kit (E plate) for evaluation of Helicobacter pylori eradication. Intern Med 2002, 41:780-783. 10.2169/internalmedicine.41.780, 12412995.
14. Fabre R, Sobhani I, Laurent-Puig P, Hedef N, Yazigi N, Vissuzaine C, Rodde I, Potet F, Mignon M, Etienne JP, et al. Polymerase chain reaction assay for the detection of Helicobacter pylori in gastric biopsy specimens: comparison with culture, rapid urease test, and histopathological tests. Gut 1994, 35:905-908. 10.1136/gut.35.7.905, 1374836, 8063217.
15. Marzio L, Angelucci D, Grossi L, Diodoro MG, Di CE, Cellini L. Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy. Am J Gastroenterol 1998, 93:223-226. 10.1111/j.1572-0241.1998.00223.x, 9468247.
16. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti- inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002, 359:14-22. 10.1016/S0140-6736(02)07273-2, 11809181.
17. Kamada T, Hata J, Kusunoki H, Sugiu K, Tanimoto T, Mihara M, Hamada H, Kido S, Dongmei Q, Haruma K. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer. J Gastroenterol Hepatol 2006, 21:98-102. 10.1111/j.1440-1746.2005.04219.x, 16706819.
18. Chan FK, Sung JJ, Chung SC, To KF, Yung MY, Leung VK, Lee YT, Chan CS, Li EK, Woo J. Randomised trial of eradication of Helicobacter pylori before non- steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997, 350:975-979. 10.1016/S0140-6736(97)04523-6, 9329511.
19. Chan FK, To KF, Wu JC, Yung MY, Leung WK, Kwok T, Hui Y, Chan HL, Chan CS, Hui E, et al. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti- inflammatory drugs: a randomised trial. Lancet 2002, 359:9-13. 10.1016/S0140-6736(02)07272-0, 11809180.
20. Hawkey CJ, Tulassay Z, Szczepanski L, van Rensburg CJ, Filipowicz-Sosnowska A, Lanas A, Wason CM, Peacock RA, Gillon KR. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention. Lancet 1998, 352:1016-1021.
21. de Leest HT, Steen KS, Lems WF, Bijlsma JW, Van de Laar MA, Huisman AM, Vonkeman HE, Houben HH, Kadir SW, Kostense PJ, et al. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial. Helicobacter 2007, 12:477-485. 10.1111/j.1523-5378.2007.00543.x, 17760715.
22. Fu S, Ramanujam KS, Wong A, Fantry GT, Drachenberg CB, James SP, Meltzer SJ, Wilson KT. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 1999, 116:1319-1329. 10.1016/S0016-5085(99)70496-8, 10348815.
23. Tatsuguchi A, Sakamoto C, Wada K, Akamatsu T, Tsukui T, Miyake K, Futagami S, Kishida T, Fukuda Y, Yamanaka N, et al. Localisation of cyclooxygenase 1 and cyclooxygenase 2 in Helicobacter pylori related gastritis and gastric ulcer tissues in humans. Gut 2000, 46:782-789. 10.1136/gut.46.6.782, 1756437, 10807888.
24. Wambura C, Aoyama N, Shirasaka D, Sakai T, Ikemura T, Sakashita M, Maekawa S, Kuroda K, Inoue T, Ebara S, et al. Effect of Helicobacter pylori-induced cyclooxygenase-2 on gastric epithelial cell kinetics: implication for gastric carcinogenesis. Helicobacter 2002, 7:129-138. 10.1046/j.1083-4389.2002.00069.x, 11966873.
25. Wambura C, Aoyama N, Shirasaka D, Kuroda K, Maekawa S, Ebara S, Watanabe Y, Tamura T, Kasuga M. Influence of gastritis on cyclooxygenase-2 expression before and after eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 2004, 16:969-979. 10.1097/00042737-200410000-00004, 15371919.
26. Meyer F, Ramanujam KS, Gobert AP, James SP, Wilson KT. Cutting edge: cyclooxygenase-2 activation suppresses Th1 polarization in response to Helicobacter pylori. J Immunol 2003, 171:3913-3917.
27. Kim TI, Lee YC, Lee KH, Han JH, Chon CY, Moon YM, Kang JK, Park IS. Effects of nonsteroidal anti-inflammatory drugs on Helicobacter pylori-infected gastric mucosae of mice: apoptosis, cell proliferation, and inflammatory activity. Infect Immun 2001, 69:5056-5063. 10.1128/IAI.69.8.5056-5063.2001, 98600, 11447186.
28. Cutler AF, Prasad VM, Santogade P. Four-year trends in Helicobacter pylori IgG serology following successful eradication. Am J Med 1998, 105:18-20. 10.1016/S0002-9343(98)00134-X, 9688016.
29. de Leest HT, Steen KS, Lems WF, Bijlsma JW, Van de Laar MA, Huisman AM, Vonkeman HE, Houben HH, Kadir SW, Kostense PJ, et al. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial. Helicobacter 2007, 12:477-485. 10.1111/j.1523-5378.2007.00543.x, 17760715.
30. Meijer BC, Thijs JC, Kleibeuker JH, van Zwet AA, Berrelkamp RJ. Evaluation of eight enzyme immunoassays for detection of immunoglobulin G against Helicobacter pylori. J Clin Microbiol 1997, 35:292-294. 229561, 8968930.
31. van de Wouw BA, de Boer WA, Jansz AR, Roymans RT, Staals AP. Comparison of three commercially available enzyme-linked immunosorbent assays and biopsy-dependent diagnosis for detecting Helicobacter pylori infection. J Clin Microbiol 1996, 34:94-97. 228738, 8748281.
32. Kisa O, Albay A, Mas MR, Celasun B, Doganci L. The evaluation of diagnostic methods for the detection of Helicobacter pylori in gastric biopsy specimens. Diagn Microbiol Infect Dis 2002, 43:251-255. 10.1016/S0732-8893(02)00409-1, 12151183.
33. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, et al. Management of Helicobacter pylori infection-the Maastricht IV/ Florence Consensus Report. Gut 2012, 61:646-664. 10.1136/gutjnl-2012-302084, 22491499.
34. Technical annex: tests used to assess Helicobacter pylori infection Working Party of the European Helicobacter pylori Study Group. Gut 1997, 41(Suppl 2):S10-S18. Technical annex: tests used to assess Helicobacter pylori infection.
35. Lindsetmo RO, Johnsen R, Eide TJ, Gutteberg T, Husum HH, Revhaug A. Accuracy of Helicobacter pylori serology in two peptic ulcer populations and in healthy controls. World J Gastroenterol 2008, 14:5039-5045. 10.3748/wjg.14.5039, 2742932, 18763287.
36. Kokkola A, Rautelin H, Puolakkainen P, Sipponen P, Farkkila M, Haapiainen R, Kosunen TU. Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: comparison of histology, 13C-urea breath test, and serology. Scand J Gastroenterol 2000, 35:138-141. 10.1080/003655200750024290, 10720110.
37. Marchildon P, Balaban DH, Sue M, Charles C, Doobay R, Passaretti N, Peacock J, Marshall BJ, Peura DA. Usefulness of serological IgG antibody determinations for confirming eradication of Helicobacter pylori infection. Am J Gastroenterol 1999, 94:2105-2108. 10.1111/j.1572-0241.1999.01285.x, 10445535.
38. Gu Q, Xia HH, Wang WH, Wang JD, Wong WM, Chan AO, Yuen MF, Lam SK, Cheung HK, Liu XG, et al. Effect of cyclo-oxygenase inhibitors on Helicobacter pylori susceptibility to metronidazole and clarithromycin. Aliment Pharmacol Ther 2004, 20:675-681. 10.1111/j.1365-2036.2004.02168.x, 15352916.
39. Park SH, Park DI, Kim SH, Kim HJ, Cho YK, Sung IK, Sohn CI, Jeon WK, Kim BI, Keum DK. Effect of high-dose aspirin on Helicobacter pylori eradication Dig Dis Sci 2005, 50:626-629.
40. Wang WH, Wong WM, Dailidiene D, Berg DE, Gu Q, Lai KC, Lam SK, Wong BC. Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents. Gut 2003, 52:490-495. 10.1136/gut.52.4.490, 1773581, 12631656.